Prognosis of diabetic patients with MI

Cardiology Review

Volumn 18, Issue 11, 2001, Pages 24-28

  Gustafsson, I ^a   Hildebrandt, P ^a   Seibaek M ^a   Melchior, T ^a   Torp Pedersen, C ^a   Kober L ^a   Kaiser Nielsen, P ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIET THERAPY; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; REVIEW; SMOKING;

EID: 0034751836     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Diabetes and cardiovascular risk factors: The Framingham study
2. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries
3. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic agents
4. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
5. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction
6. The Trandolapril Cardiac Evaluation (TRACE) study: Rationale, design and baseline characteristics of the screened population
7. A clinical trial of the angiotensin-converting-enzyme inhibitor trandol-april in patients with left ventricular dysfunction after myocardial infarction
8. An echocardiographic method for selecting high-risk patients shortly after acute myocardial infarction, for inclusion in multicentre studies (as used in the TRACE study). Trandol-april cardiac evaluation
9. Recent trends in acute coronary heart disease - Mortality, morbidity, medical care, and risk factors
10. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction
11. Clinical characteristics left and logn-term prognosis in patients with non-insulin-dependant diabetes surviving an acute myocardial infarction
12. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis
13. Radionucline assesstment of left ventricular function in patients with myocardial infarction and diabetes mellitus
14. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction
15. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year